Medi-3617

DB33765InvestigationalProtein Based Therapies

Medi-3617: Overview.

Code names
Medi-3617

Resolves to

Compound
UNII6RH6DL8R4LChEMBLCHEMBL2109298

What you can answer from here — as of August 27, 2026

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Medi-3617, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In